Keywords: جمسیتابین; Targeted nanoparticles; Tumor-targeting peptide; Squalene nanoparticles; Pancreatic cancer; Gemcitabine
مقالات ISI جمسیتابین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: جمسیتابین; Azoreductase; Polyphosphazene; Colon-specific; Methotrexate; Gemcitabine;
Keywords: جمسیتابین; 5-FU; 5-fluorouracil; AR; apoptotic resistance; ASK1; apoptosis signal-regulating kinase 1; BD,; bruceine D; COX-2; cyclooxygenase-2; EGCG,; epigallocatechin-3-gallate; EGFR,; epidermal growth factor receptor; EriB; eriocalyxin B; ERK,; extracellular sign
Keywords: جمسیتابین; Thymoquinone analogs; Molecular Docking; Pancreatic cancer; Thymoquinone; Chemosensitisation; Gemcitabine;
Keywords: جمسیتابین; Biliary tract cancer; Gemcitabine; Capecitabine; Cetuximab;
Keywords: جمسیتابین; Meta-analysis; Advanced pancreatic cancer; Gemcitabine; Combination therapy;
Keywords: جمسیتابین; Comb-like copolymers; Nanomicelles; Gemcitabine; PEG; Antitumor activity
Keywords: جمسیتابین; Nanocarriers; Immunogenic cell death; Dendritic cells; Oxaliplatin; Gemcitabine; Pancreatic cancer
MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model
Keywords: جمسیتابین; Pancreatic cancer; PDOX; Trametinib; Gemcitabine; Combination; Cancer resistance; Indvidualized therapy; Precision medicine;
Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-Invasive Bladder Cancer: Results of a Phase 2 Trial
Keywords: جمسیتابین; Bladder cancer; Urothelial carcinoma; Biomarkers; Neoadjuvant chemotherapy; Gemcitabine; Cisplatin;
Ultra-sensitive LC-MS/MS method for the quantification of gemcitabine and its metabolite 2â²,2â²-difluorodeoxyuridine in human plasma for a microdose clinical trial
Keywords: جمسیتابین; Gemcitabine; dFdU; microdose; Pharmacokinetics; Validation; LC-MS/MS;
The high stromal SPARC expression is independently associated with poor survival of patients with resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine in combination with S-1 or adjuvant gemcitabine alone
Keywords: جمسیتابین; Pancreatic cancer; Gemcitabine; Secreted protein acidic and rich in cysteine;
Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy
Keywords: جمسیتابین; urinary bladder neoplasms; M-VAC protocol; gemcitabine; cisplatin; mortality; aMVAC; accelerated MVAC; CSS; cancer specific survival; ddMVAC; dose dense MVAC; GC; gemcitabine and cisplatin; LVI; lymph node invasion; MVAC; methotrexate, vinblastine, doxoru
Ãtude comparative de coûts entre les poches de gemcitabine prêtes à l'emploi et une fabrication en unité de reconstitution
Keywords: جمسیتابین; Poches prêtes à l'emploi; Gemcitabine; Ãtude de coûts comparés; Ready-to-administer bag; Gemcitabine; Compared cost;
Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling
Keywords: جمسیتابین; Pancreatic ductal adenocarcinoma; Integrin β1; Gemcitabine; Cdc42; PI3K p110β signaling;
Uptake-release by MSCs of a cationic platinum(II) complex active in vitro on human malignant cancer cell lines
Keywords: جمسیتابین; MPM; malignant pleural mesothelioma; GBM; glioblastoma multiforme; PAC; pancreatic adenocarcinoma; GCB; gemcitabine; CisPt; cisplatin; MSCs; mesenchymal stromal cells; caPt(II)-complex; cationic platinum(II) complex; CFPAC-1; pancreatic carcinoma cell lin
Design, characterization, and in vitro antiproliferative efficacy of gemcitabine conjugates based on carboxymethyl glucan
Keywords: جمسیتابین; Gemcitabine; Carboxymethyl glucan; Amino acid linker; Conjugate; Antiproliferative activity;
Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie'
Keywords: جمسیتابین; Erlotinib; FOLFIRINOX; Gemcitabine; Pancreatic cancer; Skin rash;
Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer
Keywords: جمسیتابین; Pancreatic cancer; Microbubbles; Gemcitabine; Ultrasound; Sonodynamic therapy; Antimetabolite therapy;
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes
Keywords: جمسیتابین; Urothelial cancer; Immunotherapy; CTLA-4; Gemcitabine; Cisplatin; Chemotherapy; DNA damage response; DDR; Metastatic;
Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01)
Keywords: جمسیتابین; Adjuvant chemotherapy; Clinical trial; Phase III; Gemcitabine; Pancreatic cancer; Health-related quality of life; S-1 (combination);
Poly (l-glutamic acid)-g-methoxy poly (ethylene glycol)-gemcitabine conjugate improves the anticancer efficacy of gemcitabine
Keywords: جمسیتابین; Gemcitabine; Nanoparticle; Pharmacokinetics; Biodistribution; Glutamic acid;
Melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (afmk) enhance chemosensitivity to gemcitabine in pancreatic carcinoma cells (PANC-1)
Keywords: جمسیتابین; Melatonin; AFMK; Gemcitabine; Human pancreatic carcinoma cells PANC-1; Apoptosis; HSP; Caspases;
Simultaneous determination of gemcitabine prodrug, gemcitabine and its major metabolite 2â², 2â²-difluorodeoxyuridine in rat plasma by UFLC-MS/MS
Keywords: جمسیتابین; Gemcitabine; Prodrug; Metabolic activation; UFLC-MS/MS; Nucleoside;
PEGylation of Carbonate Apatite Nanoparticles Prevents Opsonin Binding and Enhances Tumor Accumulation of Gemcitabine
Keywords: جمسیتابین; carbonate apatite; gemcitabine; cytotoxicity; nanoparticle; PEGylation; opsonin; protein corona; pharmacokinetics; LC/MS; proteomics;
Efficacy of inverso isomer of CendR peptide on tumor tissue penetration
Keywords: جمسیتابین; Inverso isomer; CendR peptide; Neuropilin-1 (NRP-1); Tumor penetration; Gemcitabine;
A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma
Keywords: جمسیتابین; Mesothelioma; Pleurectomy; Pneumonectomy; Gemcitabine; Cisplatin; Heated chemotherapy;
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial
Keywords: جمسیتابین; CM; complementary medicine; CT; computerized tomography; DCR; disease control rate; ECOG PS; Eastern Cooperative Oncology Group performance status; EMA; European Medicines Agency; EORTC QLQ-C30; European Organization for Research and Treatment of Cancer Q
Sensitive analysis and pharmacokinetic study of a novel gemcitabine carbamate prodrug and its active metabolite gemcitabine in rats using LC-ESI-MS/MS
Keywords: جمسیتابین; FY363; Gemcitabine; LC-MS/MS; Rat plasma; Pharmacokinetics;
N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer
Keywords: جمسیتابین; Gemcitabine; Anticancer; N-trimethyl chitosan; Drug polymer conjugates; Sustained release; Oral bioavailability;
Predicting tumour growth and its impact on survival in gemcitabine-treated patients with advanced pancreatic cancer
Keywords: جمسیتابین; PKPD; Tumour; Survival; Gemcitabine; MID3;
Aqueous extracts of Paeonia suffruticosa modulates mitochondrial proteostasis by reactive oxygen species-induced endoplasmic reticulum stress in pancreatic cancer cells
Keywords: جمسیتابین; Chinese herbal medicine; Paeonia suffruticosa; Pancreatic cancer; Proteostasis; Autophagy; Apoptosis; 5GG; penta-O-galloyl-β-D-glucose hydrate; CHM; Chinese herbal medicine; DCFDA; 2â²-7â²-dichlorofluorescin diacetate; EGFR; epidermal growth factor rec
Redox-stimuli-responsive drug delivery systems with supramolecular ferrocenyl-containing polymers for controlled release
Keywords: جمسیتابین; A549; A549 lung cancer cells; AAO; anodized alumina substrates; Ad; adamantane; ALMA; allyl methacrylate; ATRP; atom transfer radical polymerization; AuNPs; gold nanoparticles; CAC; critical aggregation concentration; CB[7]; cucurbituril; β-CD; β-cyclod
Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer
Keywords: جمسیتابین; Pancreatic cancer; Acquired resistance; Methionine dependence; Gemcitabine; Oral administration; PDOX;
Effective light-triggered contents release from helper lipid-incorporated liposomes co-encapsulating gemcitabine and a water-soluble photosensitizer
Keywords: جمسیتابین; Cancer; Gemcitabine; Liposome; Near-infrared (NIR)-laser; Talaporfin sodium; Triggered release;
ZH-1 enhances the anticancer activity of gemcitabine via deoxyribonucleotide synthesis and apoptotic pathway against A549 cells
Keywords: جمسیتابین; Gemcitabine; ZH-1; Apoptosis; Deoxyribonucleotides; Intrinsic apoptotic pathway; ATCC; American Type Culture Collection; ATP; adenosine-triphosphate; ATP13C15N; trioctylamine, 1,1,2-trichlorotrifluoroethane, stable isotope labeled adenosine-13C1015N5-trip
Inhibition of MAPKAPK2/MK2 facilitates DNA replication upon cancer cell treatment with gemcitabine but not cisplatin
Keywords: جمسیتابین; MAPKAPK2; MK2; Gemcitabine; Cisplatin; p38; DNA damage; DNA replication; DNA fiber assays;
Gemcitabine-loaded gold nanospheres mediated by albumin for enhanced anti-tumor activity combining with CT imaging
Keywords: جمسیتابین; Lung cancer; Gemcitabine; Gold nanosphere; Anti-tumor; Computed tomography;
Gemcitabine-loaded DSPE-PEG-PheoA liposome as a photomediated immune modulator for cholangiocarcinoma treatment
Keywords: جمسیتابین; Gemcitabine; Biliary tract cancer; Photodynamic therapy; Liposome; Immunotherapy;
Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides
Keywords: جمسیتابین; Gemcitabine; Cell-penetrating peptides; pVEC; Penetratin; Cancer;
Microangiopathie thrombotique secondaire à la gemcitabine : peut-on améliorer le dépistage et la prise en charge ?
Keywords: جمسیتابین; Dépistage; Ãculizumab; Gemcitabine; Microangiopathie thrombotique; Eculizumab; Gemcitabine; Screening; Thrombotic microangiopathy;
Effect of taurine on immune function in mice with T-cell lymphoma during chemotherapy
Keywords: جمسیتابین; Taurine; T-cell lymphoma; Gemcitabine; Immune function;
Long-term results of a phase II study of gemcitabine and cisplatin chemotherapy combined with intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma
Keywords: جمسیتابین; Gemcitabine; Cisplatin; Intensity-modulated radiotherapy; Nasopharyngeal carcinoma; Chemotherapy;
Interleukin-27 inhibits malignant behaviors of pancreatic cancer cells by targeting M2 polarized tumor associated macrophages
Keywords: جمسیتابین; Pancreatic cancer; Interleukin-27; Tumor associated macrophages; Gemcitabine; Metastasis;
Curcumin and its cyclohexanone analogue inhibited human Equilibrative nucleoside transporter 1 (ENT1) in pancreatic cancer cells
Keywords: جمسیتابین; Curcumin (PubChem CID: 969516); Gemcitabine (PubChem CID: 60750); A13 (PubChem CID: 1550234); Nitrobenzylthioinosine (PubChem CID: 65407); EF24 (PubChem CID: 77895890); Dipyridamole (PubChem CID: 3108); Curcumin; ENT1; Gemcitabine; Pancreatic cancer; EF24
Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes
Keywords: جمسیتابین; Uterine leiomyosarcoma; Adjuvant chemotherapy; Gemcitabine; Docetaxel; Survival;
Ku70 inhibits gemcitabine-induced DNA damage and pancreatic cancer cell apoptosis
Keywords: جمسیتابین; Pancreatic cancer; Gemcitabine; Ku70; DNA damage; Chemo-sensitization;
Gemcitabine-vitamin E conjugates: Synthesis, characterization, entrapment into nanoemulsions, and in-vitro deamination and antitumor activity
Keywords: جمسیتابین; Gemcitabine; Vitamin E; Tocopherols; Tocotrienols; Lipid-conjugation; Synthesis; 1H NMR characterization; Enzymatic deamination; Nanoemulsions; In-vitro anticancer activity;
Original ArticleChemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205
Keywords: جمسیتابین; Pancreatic cancer; Chemoresistance; Drug delivery; Gemcitabine; MicroRNA; Tumor suppressor;
OH-functionalization strategy in Metal-Organic Frameworks for drug delivery
Keywords: جمسیتابین; IRMOF-16; Metal Organic Frameworks; Gemcitabine; Drug delivery; DFT calculations; GCMC simulations;